Redeye is encouraged by Systemair’s strong top-line, including 5% organic growth in the third quarter. EBIT margins (adjusted for non-recurring items) were however unchanged Y/Y and lower than we hoped for. The outlook is basically unchanged and remains quite optimistic. Our forecasts are impacted by the appreciation of the SEK, and a revision in our rating model weighs on our valuation and fair value range.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/